itraconazole
Generic: itraconazole
Labeler: alembic pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
itraconazole
Generic Name
itraconazole
Labeler
alembic pharmaceuticals inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
itraconazole 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
62332-204
Product ID
62332-204_585449d8-bba8-44fb-9544-e83636d972e0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206741
Listing Expiration
2026-12-31
Marketing Start
2016-12-16
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
62332204
Hyphenated Format
62332-204
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
itraconazole (source: ndc)
Generic Name
itraconazole (source: ndc)
Application Number
ANDA206741 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 28 CAPSULE in 1 CARTON (62332-204-04)
- 100 CAPSULE in 1 CARTON (62332-204-10)
- 30 CAPSULE in 1 BOTTLE (62332-204-30)
- 500 CAPSULE in 1 BOTTLE (62332-204-71)
- 90 CAPSULE in 1 BOTTLE (62332-204-90)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "585449d8-bba8-44fb-9544-e83636d972e0", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182141", "N0000185503", "N0000190113"], "upc": ["0362332204304"], "unii": ["304NUG5GF4"], "rxcui": ["311204"], "spl_set_id": ["23126370-8d6a-4027-bd8f-860e2776ba3a"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 CAPSULE in 1 CARTON (62332-204-04)", "package_ndc": "62332-204-04", "marketing_start_date": "20161216"}, {"sample": false, "description": "100 CAPSULE in 1 CARTON (62332-204-10)", "package_ndc": "62332-204-10", "marketing_start_date": "20161216"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (62332-204-30)", "package_ndc": "62332-204-30", "marketing_start_date": "20161216"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (62332-204-71)", "package_ndc": "62332-204-71", "marketing_start_date": "20161216"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (62332-204-90)", "package_ndc": "62332-204-90", "marketing_start_date": "20161216"}], "brand_name": "ITRACONAZOLE", "product_id": "62332-204_585449d8-bba8-44fb-9544-e83636d972e0", "dosage_form": "CAPSULE", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "62332-204", "generic_name": "itraconazole", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ITRACONAZOLE", "active_ingredients": [{"name": "ITRACONAZOLE", "strength": "100 mg/1"}], "application_number": "ANDA206741", "marketing_category": "ANDA", "marketing_start_date": "20161216", "listing_expiration_date": "20261231"}